Bill Sibold, Madrigal Pharmaceuticals CEO
FDA sets spring decision date for Madrigal’s NASH treatment, days after company announced new CEO
Madrigal Pharmaceuticals announced Wednesday that the FDA has set a March deadline for its decision on Madrigal’s treatment for a liver …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
